Evidence for the use of gabapentin in the treatment of diabetic peripheral neuropathy (Q34251691)

31 July 2017

1 reference

title

Evidence for the use of gabapentin in the treatment of diabetic peripheral neuropathy (English)

1 reference

31 July 2017

0 references

B Hemstreet

1

1 reference

PubMed ID

11354388

31 July 2017

M Lapointe

series ordinal

2

1 reference

31 July 2017

1 April 2001

1 reference

31 July 2017

Clinical Therapeutics

1 reference

31 July 2017

23

1 reference

31 July 2017

4

1 reference

31 July 2017

520-531

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

31 July 2017

1 reference

7 January 2021

Diabetic neuropathy: scope of the syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Introduction to diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Diabetic neuropathy: pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Management of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Neurotrophic factors in the therapy of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Anticonvulsant drugs for management of pain: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Anticonvulsant drugs and chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Reflex sympathetic dystrophy treated with gabapentin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Gabapentin: a new tool in the treatment of neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

1 reference

7 January 2021

Case report on gabapentin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Gabapentin in acute painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

The effect of gabapentin on neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Gabapentin for treatment of pain and tremor: a large case series

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Gabapentin therapy for diabetic neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

The short-form McGill Pain Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

The McGill Pain Questionnaire: Major properties and scoring methods

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

The clinical pharmacokinetics of the new antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980058-8

7 January 2021

10.1016/S0149-2918(01)80058-8

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11354388